Evolent Health Inc (NYSE: EVH) has reported a loss for its first fiscal quarter (ending March 31) of $-0.22 versus a loss $-0.24 for the same period a year ago. Relative to the consensus estimate […]
Editas Medicine Inc (NASDAQ: EDIT) stock enjoyed a major increase of 10.4% on 5/9/24. The shares closed at $5.56. Moreover, this advance was accompanied by above average trading volume at 142% of normal. Relative to […]
Cogent Communications Holdings I (NASDAQ: CCOI) has reported E.P.S. of $-1.38 for its first fiscal quarter (ending March 31) versus $0.13 for the same period a year ago — a decline of -1162%. Relative to […]
Charles River Laboratories Inter (NYSE: CRL) has reported earnings for its first fiscal quarter (ending March 31) of $1.31 versus $2.02 for the same period a year ago — a decline of -35%. This result […]
Ceva Inc (NASDAQ: CEVA) has reported a loss for its first fiscal quarter (ending March 31) of $-0.23 versus a loss $-0.12 for the same period a year ago. This result fell short of the […]
Central Garden & Pet Co (NASDAQ: CENTA) stock closed at $39.99 on 5/9/24 after a major increase of 11.3%. Moreover, unusually high trading volume at 176% of normal accompanied the advance. The stock has risen […]
Brookfield Corp (NYSE: BN) has reported earnings for its first fiscal quarter (ending March 31) of $0.04 versus $0.05 for the same period a year ago — a decline of -20%. For the latest four […]
Audiocodes Ltd (NASDAQ: AUDC) suffers from exceptional negative changes in investment behavior: its longer term price trend turned down, and negative upside/downside volume developed. Recent notable negative changes in fundamentals have impacted Audiocodes Ltd (NASDAQ: […]
Acadia Pharmaceuticals Inc (NASDAQ: ACAD) stock suffered a major decline of -11.2% on 5/9/24. The shares closed at $15.21. Moreover, exceptionally high trading volume at 286% of normal accompanied the decline. Relative to the market […]
ADMA Biologics Inc (NASDAQ: ADMA) has reported E.P.S. of $0.08 for its first fiscal quarter (ending March 31) versus $-0.03 for the same period a year ago. For the latest four quarters through March 31, […]
Privacy Statement Terms Of Use ©2024 PriceTarget Research